Richard Hoyt
Chairman at ZYUS LIFE SCIENCES CORPORATION
Net worth: 117 687 $ as of 2024-04-29
Profile
Richard Hoyt is currently the Chairman at ZYUS Life Sciences, Inc., Chairman at ZYUS Life Sciences Corp., Managing Partner at Ozark Transaction Advisors LLC, and Vice President-Business Development at Xeris Biopharma Holdings, Inc. He previously worked as the Director at Biotechnology Research & Development Corp., Independent Director at CanniMed Therapeutics, Inc. from 2012 to 2018, Vice President-Business Development at Xeris Pharmaceuticals, Inc., and Vice President-Business Development & Licensing at Mallinckrodt Plc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-08 | 151,108 ( 0.21% ) | 117 687 $ | 2024-04-29 |
Richard Hoyt active positions
| Companies | Position | Start |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Chairman | 2020-08-31 |
| XERIS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | - |
ZYUS Life Sciences, Inc.
 ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Chairman | - |
| Ozark Transaction Advisors LLC | Corporate Officer/Principal | - |
Former positions of Richard Hoyt
| Companies | Position | End |
|---|---|---|
| CANNIMED THERAPEUTICS INC | Director/Board Member | 2018-03-14 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Director/Board Member | - |
| MALLINCKRODT PLC | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MALLINCKRODT PLC | Health Technology |
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
CanniMed Therapeutics, Inc.
 CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology CanniMed Therapeutics, Inc. operated as a biopharmaceutical company. It offered plant biotechnology research and product development programs. The firm focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded on Oct 31st, 2016 and was headquartered in Saskatoon, Canada. | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Commercial Services |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Health Technology |
| ZYUS Life Sciences Corp. | |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
| Ozark Transaction Advisors LLC |
- Stock Market
- Insiders
- Richard Hoyt
